Sun Pharma’s arm hikes stake in Ranbaxy Malaysia

09 Jan 2018 Evaluate

Sun Pharmaceutical Industries’ one of the wholly owned subsidiaries has increased its shareholding in Ranbaxy Malaysia, Malaysia, by way of further purchase of 508,313 shares of face value of MYR 1.00 each (equivalent to 6.35%) of Ranbaxy Malaysia.

Ranbaxy Malaysia is a subsidiary of the company, and the total shareholding of Sun Pharmaceutical Industries along with its wholly owned subsidiary is 79.55%, prior to this purchase of shares.

Post completion of this purchase of shares, the total holding of the company along with its wholly owned subsidiary will increase from 79.55% to 85.90% in Ranbaxy Malaysia.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.


Sun Pharma Inds. Share Price

1804.95 -13.65 (-0.75%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×